Pulse Biosciences, Inc.
PLSE· Nasdaq
PLSEPulse Biosciences, Inc.
Filed Aug 6, 2026 · 10-Q · 37 days after period end · 0001437749-26-026288
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $434.00K | $0.00 | $0.00 | $0.00 |
| Net Income | -$24.66M | -$19.17M | -$11.38M | -$9.91M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d after period end
